3164.TW
Price:
$20.5
Market Cap:
$1.77B
GenMont Biotech Incorporation engages in the research, development, production, and sale of functional probiotic products in Taiwan. The company also offers probiotics with special functions; and original formula design and manufacturing, and equipment manufacturing services on health care food, as well as cooperates in the research, production, and clinical trial of various products. GenMont Biotech Incorporation was founded in 2000 and is headquartered in Tainan City, Taiwan.
Industry
Biotechnology
IPO Date
2008-09-19
Stock Exchange
TAI
Ticker
3164.TW
According to GenMont Biotech Incorporation’s latest financial reports and current stock price. The company's current ROE is 2.91%. This represents a change of 297.26% compared to the average of 0.73% of the last 4 quarters.
The mean historical ROE of GenMont Biotech Incorporation over the last ten years is 1.69%. The current 2.91% ROE has changed 71.70% with respect to the historical average. Over the past ten years (40 quarters), 3164.TW's ROE was at its highest in in the June 2018 quarter at 6.48%. The ROE was at its lowest in in the December 2016 quarter at -16.98%.
Average
1.69%
Median
4.18%
Minimum
-18.44%
Maximum
10.60%
Discovering the peaks and valleys of GenMont Biotech Incorporation ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 210.84%
Maximum Annual ROE = 10.60%
Minimum Annual Increase = -118.50%
Minimum Annual ROE = -18.44%
Year | ROE | Change |
---|---|---|
2024 | 4.24% | 68.98% |
2023 | 2.51% | -40.56% |
2022 | 4.22% | -48.70% |
2021 | 8.22% | 79.45% |
2020 | 4.58% | 10.42% |
2019 | 4.15% | -60.87% |
2018 | 10.60% | 210.84% |
2017 | 3.41% | -118.50% |
2016 | -18.44% | 182.20% |
2015 | -6.53% | -72.97% |
The current ROE of GenMont Biotech Incorporation (3164.TW) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
3.65%
5-year avg
4.75%
10-year avg
1.69%
GenMont Biotech Incorporation’s ROE is
Company | ROE | Market cap |
---|
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like GenMont Biotech Incorporation using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like GenMont Biotech Incorporation or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the ROE?
How can you use the ROE?
What is GenMont Biotech Incorporation's ROE?
How is the ROE calculated for GenMont Biotech Incorporation (3164.TW)?
What is the highest ROE for GenMont Biotech Incorporation (3164.TW)?
What is the 3-year average ROE for GenMont Biotech Incorporation (3164.TW)?
What is the 5-year average ROE for GenMont Biotech Incorporation (3164.TW)?
How does the current ROE for GenMont Biotech Incorporation (3164.TW) compare to its historical average?